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Abstract
Key disparities between the timing and methods of assessment in animal stroke studies and
clinical trial may be part of the reason for the failure to translate promising findings. This
study investigates the development of ischemic damage after thread occlusion MCAo in the
rat, using histological and behavioural outcomes. Using the adhesive removal test we inves-
tigate the longevity of behavioural deficit after ischemic stroke in rats, and examine the prac-
ticality of using such measures as the primary outcome for future studies. Ischemic stroke
was induced in 132 Spontaneously Hypertensive Rats which were assessed for behavioural
and histological deficits at 1, 3, 7, 14, 21, 28 days, 12 and 24 weeks (n>11 per timepoint).
The basic behavioural score confirmed induction of stroke, with deficits specific to stroke
animals. Within 7 days, these deficits resolved in 50% of animals. The adhesive removal
test revealed contralateral neglect for up to 6 months following stroke. Sample size calcula-
tions to facilitate the use of this test as the primary experimental outcome resulted in cohort
sizes much larger than are the norm for experimental studies. Histological damage pro-
gressed from a necrotic infarct to a hypercellular area that cleared to leave a fluid filled cav-
ity. Whilst absolute volume of damage changed over time, when corrected for changes in
hemispheric volume, an equivalent area of damage was lost at all timepoints. Using beha-
vioural measures at chronic timepoints presents significant challenges to the basic science
community in terms of the large number of animals required and the practicalities associated
with this. Multicentre preclinical randomised controlled trials as advocated by the MultiPART
consortium may be the only practical way to deal with this issue.
Introduction
Animal models have been widely used to aid our understanding of stroke pathophysiology and
the potential effectiveness of putative therapies. However, their utility has been questioned
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because of the failure to translate positive animal model data to a successful clinical treatment.
At the core of this translational failure lie key differences in the endpoint and outcome mea-
sures between experimental and clinical studies. Assessment of neurological deficit and dis-
ability in patients months after stroke is in stark contrast to many experimental animal studies
where infarct volume assessed at acute timepoints after stroke is the main outcome reported
[1–6]. This disparity in what and when we measure prompted the STAIR recommendations
that pre-clinical studies extend monitoring to at least 30 days, and include multiple outcome
measures including both behavioural testing and infarct volume assessment [7, 8]. However,
despite being introduced over 15 years ago, these recommendations have yet to make a great
impact on translation of an acute stroke therapy [6, 9–11]. Indeed, of over 3000 experiments
collected by the CAMARADES group for systematic review, only 5% assessed outcome at
times beyond one month, with 85% assessing outcome within one week of stroke (CAMAR-
ADES, data on file).
Meeting these challenges and facilitating rigorous evaluation of candidate therapies requires a
clear understanding of methodological variability and how experiments need to be powered to reli-
ably quantify outcome. Chronic endpoints in animal models are also made challenging by survival,
paucity of detectable and long lasting behavioural deficits, and consistency in infarct size [12].
To this end, improvements to each animal model of stroke have been made to result in more
consistent infarct sizes and improved survival. For example through different thread properties
and occlusion durations in the thread occlusion model; manipulation of photosensitive dye
concentration, illumination period or laser settings in the photothrombotic model; and location
and length of artery occluded in direct occlusion models [13–16], infarcts of different size and
location can be induced with relative consistency. While reducing variability makes modelling
cheaper, it does so at the expense of generalizability. Human stroke is also highly variable.
This study aims to profile neurological deficit and histological damage in cohorts of rats
collected at varying times up to 24 weeks following transient thread occlusion stroke. In addi-
tion, we aim to examine variability in outcomes measured and the impact on sample size cal-
culations for future studies. By using a multi-cohort design allowing us to combine
behavioural measures with assessment of histology at late timepoints after stroke, we hope to
better align experimental stroke models with the clinical situation.
Materials and methods
Animals & ethics
All procedures involving animals were approved by the Animal Ethics Committee of Austin
Health (Heidelberg, Victoria, Australia, approval number 2007/2796) and performed in accor-
dance with institutional, national and the Animal Research: Reporting In Vivo Experiments
(ARRIVE) guidelines (Australian code of practice for the care and use of animals for scientific
purposes, 7th edition, 2004)[17]. Male Spontaneously Hypertensive Rats (SHR) were used
throughout this experiment (Animal Resource Centre, Canning Vale, Western Australia). All
animals were aged 15 weeks at surgery (286-362g). Blood pressure was not monitored.
Sample size calculation
Based on previous infarct volume data using an identical surgical design (90 minute thread
occlusion MCAo in 15 week old male SHR), a sample size calculation (power = 0.8; alpha = 0.05,
see below) estimated 11 animals per group would be required to detect an infarct equivalent to
25% of the uninjured hemisphere. Additional animals were allocated to longer recovery time-
points to allow for deaths and to ensure enough animals survived to each time point. A total of
132 animals underwent surgery for this experiment.
Ischemic damage and behavioural deficit over 6 months after stroke in the rat
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Randomisation and blinding regime
To reduce selection, performance, detection and attrition biases, care was taken to ensure ani-
mals were randomised to experimental group, investigators remained blinded to experimental
group for induction and assessment of ischemia, and outcomes for all animals used in the
experiment were reported. Specifically, animals were numbered upon arrival at the animal
facility. An investigator independent of the surgical procedure randomised the list of animals
to experimental group (using Excel random number generator), with surgical type (stroke or
sham) being revealed to the surgeon immediately prior to thread insertion. Animals undergo-
ing ischemia were further randomised to one of nine experimental groups that determined
when they were to be collected for histology analysis: 1, 3, 7, 14, 21, 28, 84, and 168 days follow-
ing MCAo. Sham animals (complete surgery without thread insertion) were sacrificed for his-
tology at 168 days following surgery. In the case where an animal died prior to its designated
endpoint, the animal was replaced from a pool of additional animals. Data from animals
which did not reach their designated endpoint was not included in the analysis except for a
summary of mortality. Allocation to group remained blinded throughout the behavioural
assessment, with animals carrying no identifier of experimental group. Once animals reached
their designated endpoint, tissue was collected and re-coded to ensure blinded histology. All
surgery, behavioural testing and histological analysis were performed by a single investigator.
Induction of focal ischemia
Anaesthesia was induced by inhalation of 5% isoflurane (mixed with 50:50 air and oxygen) in
an enclosed box and then maintained using a nose cone where 2% isoflurane (mixed with
50:50 air and oxygen) was delivered to the spontaneously breathing animal for the duration of
surgery. Throughout surgery, body temperature was monitored and controlled to 37.4˚C
using a rectal temperature probe controlling a heat mat (manufactured in house).
Focal cerebral ischemia was induced using the thread occlusion model of MCAo following
the methods of Longa with modifications by Spratt [16, 18]. Cerebral blood flow was moni-
tored in the area 5mm lateral, 1mm posterior to bregma by Laser Doppler flowmetry (Moor-
Lab, Devon, UK, coupled to iWORX, Dover, NH, USA). Prior to affixing the Laser Doppler
probe, the skull was thinned using a hand held drill. The right MCA was occluded for 90 min-
utes before withdrawal of the thread to allow reperfusion for the remainder of the experiment
(24 hours to 24 weeks). Briefly, a silicone coated 4–0 nylon suture of dimensions 0.35mm diam-
eter; 2mm coating length (manufactured according to Spratt et al[16]) was inserted approxi-
mately 18mm through a stump created from the External Carotid Artery to occlude the MCA
until mild resistance was felt. This coincided with a drop in blood flow. Animals were recovered
from anaesthesia following occlusion. Just prior to 90 minutes post MCAo, animals were rea-
naesthetised to permit withdrawal of the thread and reperfusion. Animals allocated to the sham
group underwent the same surgical procedure as stroke groups, without insertion of the occlud-
ing thread. This included clips being briefly placed on the ICA and CCA.
All animals were housed individually following surgery to ensure a consistent post-surgical
environment. Postoperative analgesia was provided in the form of a single rectal suppository of
paracetamol (5mg of a 20mg/kg solution). A post-operative care plan was employed to help pre-
vent weight loss and dehydration over the first week after surgery. This included the supply of
paracetamol in drinking water (120mg/kg), sub-cutaneous injections of saline (days 1–3) and pro-
vision of soft food. For the first week after surgery, animals were housed in a recovery room
where they could be closely monitored. After the seventh day post-surgery, animals were returned
to live in general holding rooms, still in individual cages. Weight, basic behaviour and general
health were monitored daily for the first two weeks following surgery, and regularly thereafter.
Ischemic damage and behavioural deficit over 6 months after stroke in the rat
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Behavioural tests
Three measures were used to assess behavioural deficit after stroke: basic behavioural scale,
adhesive removal test, and sunflower seed challenge. All three behavioural assessments were
performed at the following times: Pre, 1, 3, 7, 14, 21, 28 days, 8, 12, 16, 20, 24 weeks.
Basic behavioural scale. Neurobehavioural deficit was assessed using a modified version
of the methods described by Petullo et al to score forelimb flexion, torso twisting, lateral push
resistance, and general mobility (Table 1, Fig 1A)[19]. This test was chosen as a quick and sim-
ple assessment of neurological deficit after stroke.
Adhesive removal test. The adhesive removal test (also referred to as the sticky tape test)
has been used as a measure of motor co-ordination and sensory neglect after stroke in experi-
mental studies using rats and mice [20–27]. After a period of familiarisation in the glass test
box (30x28x45cm), the rat was lightly restrained to allow attachment of 9mm circular office
stickers (Checkpoint Systems, Kuala Lumpur, Malaysia) to the palm of each forepaw (Fig 1D).
The order of attachment (left or right applied first) was alternated at each test. Additionally,
each forepaw was touched firmly and in quick succession after attachment of the tape. The
time taken to remove each sticker was recorded. Three trials were undertaken in each test ses-
sion, with a rest period of at least 1 minute between trials. A maximum time of 150 seconds
was allocated for each trial. If the stickers could not be removed within this period, a maximum
time was recorded. Animals were acclimatized to the test procedure in the week prior to sur-
gery via 3 training sessions of 3 tests. A baseline test was recorded on the day prior to surgery.
Sunflower seed challenge. The fine motor co-ordination required to manipulate, open
and consume a sunflower seed from its husk may provide an opportunity to explore long term
deficit following stroke [28, 29]. To simplify the test, we examined the number of pieces of sun-
flower seed remaining after a set time. Rats were given sunflower seeds in their home cage to
familiarise them with shelling and consuming seeds throughout the week prior to surgery. At
each test session, rats were placed in a paper lined box with 10 sunflower seeds. After 30 min-
utes the number of whole (uneaten) seeds and pieces of shell were recorded (Fig 1G). Animals
were not fasted prior to testing.
Table 1. Scoring criteria for Basic Behavioural Test after stroke (Modified from Petullo et al)[19].
Test Score Description
Forelimb
Flexion
0 No flexion. Forelimbs extend equally outstretched toward the bench
0.5 Mild. Left forelimb at approximately 45˚ angle consistently; or angle is closer to 90˚
but is not consistent.
1 Moderate to severe. Left forelimb is at 90˚ or greater. Forelimb flexion is
consistent.
Torso
Twisting
0 No signs of body rotation. Body elongated and extended toward the bench.
0.5 Mild. Half twist of the body.
1 Moderate to severe. Consistently strong twisting to contralateral side. Head and
forelimbs brought toward hind limbs.
Lateral Push 0 Equal resistance. Animal resists being pushed.
0.5 Weakened resistance. Animal shows weakened resistance whilst trying to
correct.
1 No resistance. Animal has severely weakened resistance. Tends to “roll” with left
legs collapsing after being pushed to the left.
Mobility 0 Normal mobility. Animal is able to freely walk, move about cage, rear on
hindlimbs.
0.5 Spontaneous movement reduced.
1 Needs stimulus to move.
2 Unable to walk.
doi:10.1371/journal.pone.0171688.t001
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Tissue collection and processing
At their designated endpoint, animals were deeply anaesthetised with isoflurane and transcar-
dially perfused with 90mL normal saline followed by 270mL 4% paraformaldehyde. The brain
was removed and postfixed in paraformaldehyde for 24 hours before being cut into 2mm thick
coronal slices which were then processed and embedded in paraffin wax. Seven micron sec-
tions were collected on to silane coated microscope slides, followed by staining with hematoxy-
lin and eosin for infarct delineation.
Infarct analysis
Image acquisition. Slides were digitised using an Aperio ScanScope XT microscope (Leica
Biosystems, Wetzlar, Germany) at 20x magnification. The pen tool within ImageScope (Aperio
Technologies, Vista, CA, USA) was used to manually define hemispheres and ventricles, and to
delineate areas of ischemic injury (described below).
Definitions of damage. Progression of ischemic related damage involves many stages
which influence the structure and appearance of tissue. Normal healthy tissue was characterised
by round neuronal nuclei and cell bodies, with uniform neuropil staining. The absence of normal
cells was used to define the boundary for outlining ischemic related damage. As the infarct aged
and progressed, differentiation between striatal and cortical damage became more difficult and
so we report the total area damaged. Qualitative notes were made of the location of damage.
Areas of damaged tissue were delineated based on descriptions provided in the literature
[30–33]. Vacuolation and sponginess of the neuropil, pallor of the eosiniphilic background
and the shape and staining of neuronal cell bodies were used to identify acutely damaged tissue
Fig 1. Assessment of behavioural deficit for 6 months after stroke. Basic Behavioural Test: A) Forelimb
flexion and torso twisting. B) Total score over the timecourse of the experiment. C) Presence of a deficit (shaded)
over the course of the experiment. Adhesive Removal Test: D) Placement and removal of tape on the forepaws.
E) Time to remove contralateral (left) tape relative to baseline ability. F) Time to remove ipsilateral tape relative to
baseline ability. Sunflower Seed Challenge: G) Intact and broken seeds. H) Number of whole seeds remaining. I)
Number of pieces of seed.
doi:10.1371/journal.pone.0171688.g001
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[31]. Early ischemic damage included pyknosis where cells appeared shrunken and intensely
stained, and cells with eosinophilic cytoplasm (red neurons), together with disruption of the
neuropil. Neuronal damage progressed to ghost neurons where affinity for hematoxylin was
lost, before fading into the neuropil [34]. Inflammatory cells invaded the area of damage and
could be identified by their small dark round nucleus. These cells are likely to be neutrophils
[35–37]. Macrophages also entered the ischemic area, characterised as large round cells with
an offset nucleus. As the ischemic area was cleared by phagocytosis, a dense band of glial cells
(with small nuclei and mesh like morphology) formed a border between healthy tissue and
cavity. This band was included in measurements of damaged tissue.
Calculation of infarct volume. Volume of damage was calculated based on six slices
approximately 2mm apart, ranging from 3.7 to -6.3mm relative to bregma. Area measurements
were converted to volumes by finding the average area at two adjacent planes and multiplying
by the distance between the planes. Volumes were calculated for each hemisphere, total brain
size, ventricles, damaged tissue, and healthy tissue (remaining ipsilateral tissue). To account
for differences in hemisphere size due to the effects of oedema and atrophy, total ischemic
damage was calculated as a proportion of the contralateral hemisphere using the formula
ðcontralateral area  remaining ipsilateral areaÞ
contralateral area [24].
Statistics and analysis
Statistical analyses designed by our statistician (LC) were conducted using IBM SPSS Statistics v20
and Stata 13IC (StataCorp). Groups were compared using ANOVA with Bonferroni post hoc
analysis for between group comparisons; and Dunnetts test for comparison to sham. When there
was significant variation between experimental groups (failure of Levene’s test of homogeneity of
variances), Game-Howell and Dunnett T3 post hoc tests were applied. To test for differences in
body weight over time (comparing stroke and sham animals), random-effect generalised least
squares regression was used. Linear regression was used to compare individual timepoints. Cox
regression with shared frailty, adjusting for time and baseline ability was used to examine the adhe-
sive removal test. Data for the basic behavioural test was recoded in a binary fashion (deficit / no
deficit) and examined using random effects logistic regression. Cross tabs, Fisher’s exact test and
Agresti’s generalised odds were used to examine deficit at individual timepoints [38]. Sample size
and power calculations were performed using an online calculator (http://www.statisticalsolutions.
net/pssTtest_calc.php), power = 0.8, α = 0.05. All infarct data are presented as average ± standard
deviation, with individual animal data points displayed on graphs. The degree of association
between deficit in the adhesive removal test assessed at day 1 and ischemic damage was estimated
with Pearson correlation coefficient.
Results
Summary of animal numbers
A total of 132 animals underwent surgery. Twenty-eight animals died prematurely or were
excluded from the study. Most deaths (n = 26) occurred within 21 days of stroke. Of these, 7
animals died within a day of surgery due to sub-arachnoid haemorrhage or technical error
during stroke induction. Potential infection was suspected in 7 animals, characterised by
blood clots lining the chest cavity [39, 40].
Importantly, all animals who reached their designated endpoint showed both behavioural and
histological evidence of successful stroke. Of 104 animals who reached their endpoint, 98 were
available for histological analysis; 6 brains were damaged during tissue processing (Table 2). For
Ischemic damage and behavioural deficit over 6 months after stroke in the rat
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behavioural tests, data from stroke animals was grouped and compared to sham for each assess-
ment timepoint. The number of animals tested at each time is summarised in Table 2.
Confirmation of successful stroke induction
Induction of MCAo was confirmed by a drop in blood flow at insertion of the occluding thread
and acute behavioural deficits. The average CBF decrement at MCAo relative to pre-occlusion
was 70.6±14.6%. The degree of occlusion was equivalent across all stroke groups, and signifi-
cantly different to sham (F(8,91) = 40.43, p<0.001) (Table 2).
At 90 minutes (immediately prior to reperfusion) all stroke groups had a median beha-
vioural score of 3, with scores ranging from 1.5–4, suggesting MCAo induced a similar degree
of deficit in all stroke animals. Sham animals showed no deficit 90 minutes after surgery, sug-
gesting the deficits seen in stroke animals are due to ischemia and are not caused by the surgi-
cal procedure or anaesthesia.
All animals exhibited reduction in Laser Doppler signal, behavioural deficit after with-
drawal of anaesthesia and infarction at their designated endpoint. Therefore all procedures
were considered successful.
Behavioural deficit
Basic behavioural test. Deficit in the basic behavioural test was most pronounced at 90
minutes (immediately prior to reperfusion) (Fig 1B). Deficit was still evident but less severe at
day 1 and continued to diminish over the first week. At timepoints beyond 14 days there
appears to be very little behavioural deficit detected using the basic behavioural test.
Scores were re-coded to group animals with no deficit (total score = 0), or any deficit (total
score >0.5) to allow testing of repeated assessments. Random effects logistic regression found
a significant difference between stroke and sham groups across the entire experiment (Odds
Ratio = 940.04; 95% CI: 61.64, 1436.5; p<0.001), with a significant treatment-by-time interac-
tion. When individual timepoints were considered, stroke animals were more likely to have a
deficit (any score) in the basic behavioural test than sham animals up to 7 days post-surgery
(Odds Ratio = 3.24, 95% C.I 2.34, 4.49, p<0.001) (Fig 1C). At timepoints beyond 7 days, the
basic behavioural test was not able to discriminate between stroke and sham animals as both
groups had little or no deficit (14 day Odds Ratio = 1.88, 95% C.I. 1.46, 2.43, p = 0.063). Of the
test components, forelimb flexion had the most longstanding (and strongest) deficit, but at
later timepoints only a small proportion of animals (12.5%, n = 2) still had evidence of fore-
limb flexion.
Table 2. Summary of cohort sizes, CBF drop at MCAo and Tissue Damage (Mean±Standard Deviation).
24 hours 3 days 7 days 14 days 21 days 28 days 12 weeks 24 weeks Sham
n Behavioural
Assessment
93 83 73 62 51 40 29 15 9
Reached Endpoint 11 11 11 11 11 11 13 16 9
Infarct Analysis 11 11 11 10 11 11 12 15 6
CBF decrement at
occlusion (% of baseline)
73.3±9.9 65.5±14.0 66.3±17.6 73.5±8.0 70.4±15.6 74.4±11.0 66.7±19.1 73.0±17.0 -24.3±24.3
Reperfusion Recovery (%
of pre MCAo)
74.5±77.4 113.6
±81.7
127.6
±150.7
109.3
±144.1
312.4
±382.7
160.7
±269.9
120.6
±121.7
285.0
±692.3
125.2
±103.0
Volume of Damage (mm3) 134.4
±50.1
142.2
±43.4
93.7±33.5 88.9±29.1 93.7±27.8 80.9±20.6 50.1±23.5 60.7±24.7 4.5±9.9
Total Ischemic Damage (%) 28.5±9.8 29.5±9.0 26.0±6.9 34.4±12.0 33.0±9.8 32.8±7.8 26.3±9.0 29.1±12.6 5.1±5.2
doi:10.1371/journal.pone.0171688.t002
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Adhesive removal test. Prior to surgery, all animals were able to remove the tape rapidly
(13±8 sec; 14±9 sec contralateral (left) and ipsilateral (right) forepaw respectively) and did not
show preference in the order in which tapes were removed. Following induction of MCAo,
pronounced deficit in their ability to remove the contralateral tape was observed (Fig 1E). This
continued as an asymmetric bias to remove the ipsilateral tape before attempting to remove
the contralateral tape for the entire observation period. Across all timepoints assessed, median
time to remove the contralateral tape was 44±5 seconds (95% CI: 33.0, 51.67) for stroke ani-
mals, and 6±0 seconds (95% CI: 4.67, 6.33) for sham. Stroke animals were 94% less likely to
remove the contralateral tape at any time over the 6 month experimental period compared to
sham (Cox regression with shared fragility and adjustments for time and baseline ability. Haz-
ard ratio = 0.063 (95% CI: 0.034, 0.115; p<0.001)). When individual timepoints were com-
pared, stroke animals consistently removed the contralateral tape significantly slower than
sham animals for all timepoints except 112 days (Fig 1E).
Impairments were also evident in the time to remove the ipsilateral tape (HR = 0.557; 95%
CI: 0.339, 0.913; p = 0.020) (Fig 1F). When individual timepoints were examined, there were
significant differences between stroke and sham animals in the time to remove the ipsilateral
tape for the first week after stroke (Fig 1F). Beyond 7 days, there was no significant difference
between stroke and sham animals, with each as likely to remove the ipsilateral tape.
Sunflower seed challenge. Prior to surgery, all animals could readily break all 10 sun-
flower seeds open, resulting in 34±8 pieces. Over the acute 3 days following surgery, many
stroke and some sham animals did not open some (or all) sunflower seeds (Fig 1H). During
the first 14 days, stroke animals broke sunflower seeds into fewer pieces than sham, leaving
more seeds untouched (Fig 1I). After 14 days, stroke and sham animals broke sunflower seeds
into an equivalent number of pieces. In its current form, this test does not appear useful for
discriminating between stroke and sham animals, nor for assessing deficits after stroke.
Evolution of ischemic related damage
Damage resulting from tMCAo developed rapidly, with an infarct encompassing the cortex
and striatum evident by 24 hours. The volume of damage was largest at 3 days post stroke
(142.2±43.4mm3) (Table 1, Fig 2A). From day 7 to 28 the volume of damage was smaller but
stable, however the composition of this area of damage included larger volumes of cavity over
time (Fig 2A). Cavity was first evident as small patches at 7 days, and became prominent in
most animals by 14 days. The volume of cavity was largest at 24 weeks, representing 26.2% of
the total damage (15.9±9.2mm3 cavity; 60.7±24.7mm3 total volume of damage). Infarct volume
differed significantly over time (F(8,89) = 15.649, p<0.001), with all stroke groups significantly
Fig 2. Ischemic damage over time after stroke. A) Total volume of damage including cavity (shaded). B)
Changes in hemispheric size C) Ischemic damage corrected for the effect of oedema and atrophy. All values
Mean±Standard Deviation. Animals are represented by individual data points. * p<0.05
doi:10.1371/journal.pone.0171688.g002
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different to sham. Animals collected at 24 hours and 3 days had infarct volumes significantly
larger than animals collected at 12 and 24 weeks (and 28 days for 3 day comparison) (p<0.05).
Changes in hemispheric size were evident early after stroke as an enlargement of the ipsilat-
eral hemisphere relative to its contralateral counterpart (Fig 2B). Swelling of the ipsilateral
hemisphere peaked at 3 days. By 7 days the effect of oedema had resolved, with ipsilateral and
contralateral hemispheres being of a similar size, and comparable to sham. Beyond 14 days,
the ipsilateral hemisphere was consistently smaller than the contralateral hemisphere, suggest-
ing atrophy. The difference between ipsilateral and contralateral hemispheres differed signifi-
cantly over time F(8,95) = 17.662, p<0.001. Only the 7 and 14 day groups did not differ from
sham.
When the amount of tissue damaged was adjusted for differences in hemisphere size (due
to the degree of atrophy or oedema), the proportion of ischemic damage was equivalent across
all stroke groups (26.0±6.9%–34.4±12.0%) (Table 1, Fig 2C). One way ANOVA showed a sig-
nificant difference in tissue loss between experimental groups (F(8, 89) = 5.592, p<0.001). All
stroke groups had significantly greater tissue loss compared to sham (p<0.05). There was no
difference in tissue loss between stroke groups collected at different timepoints, suggesting an
equivalent volume of brain is damaged across all stroke animals after 90 minutes tMCAo in
the SHR.
When the degree of deficit was compared with final ischemic damage, the best correlation
was seen when comparing time to remove the contralateral tape in the adhesive removal test at
day 1, when the deficit was most severe, with infarct volume measured at 24 weeks after stroke
(r = 0.739, p = 0.003, n = 14).
Qualitative description of damage. Ninety minute transient MCAo in the SHR resulted
in damage to the right striatum and cortex of all animals. Over time, more animals showed
damage to the hypothalamus, hippocampus and thalamus (54% at 3 days, 54% at 21 days, 75%
at 12 weeks respectively). Across all timepoints, scattered necrosis was noted in the contralat-
eral hemisphere.
As time progressed after stroke onset, tissue structure and the type and extent of damage
differed. Sham animals generally showed normal histology on H&E stained sections, charac-
terised by large neuronal nuclei and uniform neuropil. Early ischemic damage was typified by
red neurons with shrunken pyknotic nuclei, eosinophilic cytoplasm and a “halo” where they
had retracted from the surrounding neuropil (Fig 3A ii and 3B ii). The area of infarct showed
vacuolation, sponginess, and a general sparseness of the neuropil. At 3 days, many neurons
had taken on the ghost profile, fading into the background. Both striatum and cortex showed
hemorrhagic transformation (Fig 3A iii and 3B iii). By 7 days the area of ischemic damage
became hypercellular, packed with macrophages and other infiltrating cells. Within the dam-
aged striatum, infiltrating cells were generally localised within the white matter bundles (Fig
3A iv). Clearance of ischemic tissue progressed through 14 and 21 days, with all animals show-
ing growing areas of cavity amid a diffuse matrix of fine connective tissue at 21 days (Fig 3A vi
and 3B v, vi). By 28 days a dense band of cells provided a border between damaged and intact
tissue (Fig 3B vii). At 12 and 24 weeks, large portions of the ischemic area were a fluid filled
cavity. Three animals showed mineral deposition within the thalamus.
Sample size calculations
As the adhesive removal test showed persistent deficit in stroke animals for the entire experi-
mental period, we calculated the sample size required to detect different degrees of recovery
across the range of timepoints examined here (Table 3). When comparing to a sham group to
detect the presence of a stroke, manageable cohort sizes of 9–36 (1 day and 24 weeks
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respectively) make the adhesive removal test a practical outcome measure. However, calcula-
tions to support differing degrees of recovery between stroke groups indicate that much larger
numbers of animals would be required. For example, to detect a 25% improvement in beha-
vioural deficit at 28 days, 842 animals per cohort would be required.
When ischemic damage was considered the primary outcome, the required number of ani-
mals per cohort was smaller due to decreased variability (compared to the adhesive removal
test) (Table 3). For the same example of 25% difference in ischemic damage assessed at 28
days, 15 animals per cohort would be required.
Discussion
There are many challenges associated with bringing animal models of stroke in line with clini-
cal studies, meeting the STAIR criteria and achieving this using a rigorous experimental
design. These challenges include survival, long lasting and detectable behavioural deficits, and
Fig 3. Evolution of ischemic related damage resulting from MCAo. Representative images taken through the centre of
the area of damage at approximately 1.7mm relative to bregma. A) Striatum. B) Cortex. Scale bar represents 50μm. Filled
arrow head = red neuron; Open arrow head = hemorrhagic transformation; Arrow = Ghost neuron; Dotted line = striatal bundle;
Star = Glial scar.
doi:10.1371/journal.pone.0171688.g003
Table 3. Sample size calculations for behavioural and histological based outcome measures.
Behaviour–Adhesive Removal Test Ischemic Damage
Time of assessment
post stroke
Sham 10%
recovery
25%
recovery
50%
recovery
75%
recovery
10%
difference
25%
difference
50%
difference
75%
difference
1 day 9 809 130 33 15 186 30 8 4
3 days 9 810 130 33 15 147 24 6 3
7 days 18 1,847 296 74 33 111 18 5 2
14 days 25 3,417 547 137 61 192 31 8 4
21 days 24 3,952 633 159 71 139 23 6 3
28 days 13 5,262 842 211 94 89 15 4 2
12 weeks 23 4,284 686 172 77 184 30 8 4
24 weeks 36 12,581 2,013 504 224 295 48 12 6
doi:10.1371/journal.pone.0171688.t003
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consistency in successful stroke induction and infarct size [12]. In this study, we aimed to
explore long term outcomes in groups of rats after stroke, focussing on behavioural and histo-
logical endpoints.
Survival
A key difference in outcome measures between clinical and experimental studies is the report-
ing of mortality. Outcome from a clinical treatment is often assessed by improvements in mor-
tality [41], whereas mortality is rarely reported in the experimental literature, or included as
part of outcome assessments [42–44]. Our animal models have been tailored to reduce mortal-
ity associated with the stroke and maximise survival, both for ethical and financial reasons.
When it is reported, mortality following stroke in laboratory animals is in the order of 25%
within 24 hours of stroke onset [45–50]. During the following days where oedema is maximal,
mortality can increase to 33% [26, 51]. Nonetheless, honest reporting of animal numbers,
including those that died and the reasons for it are important in taking animal models of
stroke forward [44].
We have shown that moderately large infarct involving the MCA supplied cortex and stria-
tum can be consistently induced in SHR rats with mortality (21%) broadly limited to two key
periods–sub-arachnoid haemorrhage at thread insertion and development of suspected infec-
tion within 21 days. The ability to maintain animals for up to 6 months after stroke with lim-
ited mortality beyond the acute period is encouraging. This is entirely consistent with human
data where mortality within 28 days is in the order of 28% [52, 53].
Whilst models that induce smaller infarcts such as photothrombosis can result in reduced
mortality, they do not permit the study of reperfusion, and recovery of behavioural deficit is
often rapid [54–56]. Long term studies involving mouse models of stroke have proven espe-
cially challenging, with mice being particularly susceptible to post-stroke infection [57] and
inadequate food/water intake [58]. In this regard it is interesting that sham animals here exhib-
ited difficulty consuming sunflower seeds during the acute post-surgical period, presumably
because of ischemia to the muscles of the jaw [59]. These factors contribute to mortality in
mouse stroke models being much higher than rats, up to 90% [60, 61].
Detectable and long lasting behavioural deficits
The ability to detect and assess stroke related deficits for long period of time after stroke is a
priority for the future use of animal models. For many of the tests in routine preclinical use,
spontaneous recovery occurs rapidly after stroke, making long term studies challenging [11,
62–65]. However, understanding the profile of behavioural deficit and its recovery in different
tests is important, as it will influence the interpretation of the effect of treatments on stroke
outcome [65]. Whilst this study did not aim to recommend any specific test/s, we did want to
determine the longevity of impairments and our ability to detect them after stroke.
Regular assessment of behavioural deficit in 104 animals for up to 24 weeks post stroke found
rapid development of impairments specific to stroke animals. Whilst some deficits were acute
and resolved rapidly, the basic behavioural test allowed discrimination between stroke and sham
animals for the first week following stroke. Behavioural scales such as this have become popular
tools for assessing stroke related deficits because they are simple to perform and require no spe-
cialised equipment, making them ideal for early assessment of stroke animals. Assessment scales
such as the basic behavioural test used here may be akin to the NIHSS as they are most frequently
used (and useful) during the early period after stroke. Being able to assess ischemia induced defi-
cits quickly and easily early after the onset of MCAo is important. It allows screening of animals
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to assess the success of stroke induction, and offers the opportunity to randomise animals with
equivalent neurological deficit into experimental treatment groups in equal proportions [26, 66].
Similar to other studies, we found the adhesive removal test effective in detecting long last-
ing deficits after stroke, with stroke animals significantly slower than shams to remove the con-
tralateral tape for the entire experimental period [24, 25, 67–73]. However the ability of a test
to detect behavioural deficit may in part depend on the location and size of the ischemic dam-
age. For example, Trueman et al recently found no deficit in the adhesive removal test at 1 and
2 months post stroke [65]. The shorter occlusion duration of 30 minutes in Trueman’s study
may have resulted in milder deficits and/or smaller infarct that did not involve the somatosen-
sory cortex, or only mild damage that was amenable to recovery within 1 month.
The adhesive removal test is very relevant in linking experimental and clinical stroke, as it
was originally based on the double simultaneous stimulation examination of contralateral
neglect [74, 75]. Furthermore, it has been used across multiple species, namely mice, rats, ger-
bils and marmosets [20, 23, 24, 76, 77].
Consistency in ischemic damage
Histological assessment of infarct volume remains the most frequently reported outcome in
experimental stroke studies. This has followed the belief that reduction in infarct size is an
indication that a therapy is neuroprotective, and will improve outcome for patients.
Evolution of ischemic damage after tMCAo occurs rapidly and as a function of time, involv-
ing four key stages: necrosis, inflammation, organisation, and resolution [78, 79]. Each stage
follows in sequence: The infiltration of inflammatory cells is triggered by the initial necrosis.
In turn, infiltrating macrophages facilitate clearance of necrotic tissue and formation of a fluid
filled cavity. The rate of progression from neuronal necrosis to cavity formation was similar to
that described by others [31, 37, 80]. However, this study adds to our understanding of the his-
tological damage after stroke as it encompasses a greater number and range of timepoints
(together with larger animal numbers) than previous studies (which have generally used only
3–4 animals per timepoint) [30, 31, 37, 79–81]. The randomised and blinded induction of
ischemia and assessment of damage further enhance the value of the data presented here.
As the cellular and connective tissue makeup of the damaged area changes with progres-
sion of the infarct, this study highlights how the way in which damage is expressed becomes
an important factor in order to allow comparisons across groups collected at different times
post stroke. When the effects of oedema and atrophy were removed to allow expression of
damage as one of total ischemic damage (as a proportion of contralateral hemisphere), all
groups showed a similar proportion of damage. Together with similar CBF drop at MCAo
and acute behavioural deficits, this suggests that there was good consistency in the area to
experience ischemia, with this area going on to infarction, resolution and cavity formation.
This highlights that our model has consistently induced ischemia to the MCA supplied cor-
tex and striatum. Moreover, it suggests that this measure may allow better comparison of
damage across experiments by different groups and could be introduced as a core assess-
ment technique.
Volumetric measurements of damage alone do not reflect the structural and cellular
changes occurring within the ischemic brain. Therefore, both qualitative and quantitative
assessments must be made in order to appreciate the type and extent of ischemic damage,
especially where multiple timepoints are being considered [11].
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Selecting appropriate endpoints and outcome measures
Selection of an appropriate outcome method and the time at which to assess stroke animal
models are important considerations in experimental design. Understanding the variability in
different outcome measures over time post stroke ensures an appropriate number of animals
are assigned to each cohort to provide robust results. Similarly, we need to power our experi-
ments for the most relevant outcome measure, and be mindful that other secondary outcome
measures may not be powered for appropriately.
Using the most common outcome, histological damage, sample size calculations for differ-
ent endpoints (and degrees of effect) found group sizes up to 12 animals could detect large
effects (50 and 75% reduction in ischemic damage) across all timepoints. However, when
smaller and probably more realistic effect sizes were considered (10 and 25% reduction in
ischemic damage), much larger cohort sizes were required. When behavioural outcomes
(adhesive removal test) were considered the primary measure, cohort sizes were greater again,
given the larger degree of variability in performance.
The question of what and when to assess animal models of stroke will depend on each
experiment and the hypothesised effect of the treatment. Whilst changes in infarct volume
have been the most commonly reported outcome, it may not be the most useful in finding a
treatment that will translate for acute stroke patients. Considering behavioural outcomes as
the primary assessment would require a larger number of animals, akin to a clinical trial. This
exploratory exercise presents challenges in aligning animal models with clinical stroke. The
number of animals estimated here far outnumber the cohort sizes of 6–12 animals generally
used in experimental studies and would present a practical and logistical challenge for any
individual laboratory to undertake for a single study [82–85]. However collaborative efforts
between laboratories may make such approaches more feasible [3, 86–88]. The methodologies
required for such an approach have been developed by the EU funded Multi-PART consor-
tium (http://www.dcn.ed.ac.uk/multipart/about.html).
It is also likely that different models, species and strains will produce different results, and
require different numbers of animals per group. For example, Rosell showed that across differ-
ent strains of mouse, the number of animals required per group ranged from <10 to>100
depending on the test and time examined [89]. Similarly, models that induce smaller, more
consistent infarcts such as Endothelin-1 would lead to a smaller number of animals in each
cohort [83].
Limitations
In this study we aimed to reduce variability in infarct size by inducing stroke of 90 minutes
duration in 15 week old male SHR rats. In order to understand stroke biology better and
improve translation, replication and extension of this study to include females, aged animals,
and animals with co-morbidities are required as these factors will all impact the development
of ischemic damage and the resulting behavioural deficit [64]. Understanding the impact of
each of these factors (and in combination) are important goals for researchers.
We limited our study to three behavioural tests of which the adhesive removal test proved
most useful consistent with its links with neglect in patients. However there are a vast range of
tests worth exploring for long term deficits after stroke [63]. Ultimately a battery of behavioural
tests seems likely to be required but will need to be validated at extended times post-stroke.
Time and costs prevented such validation in this study. A recent detailed study by Trueman
et al assessed a range of tests and their ability to detect deficits at 2 months after stroke in rats
[65]. Differences between species, strains, models, and within model conditions all need to be
considered carefully when deciding whether a behavioural test is appropriate for the study.
Ischemic damage and behavioural deficit over 6 months after stroke in the rat
PLOS ONE | DOI:10.1371/journal.pone.0171688 February 9, 2017 13 / 19
Assessment of histological damage was limited to H&E staining in this study. Further
exploration of the histological damage induced by stroke and the long term consequences of it
are warranted. In addition, histology only provides a snapshot of the ischemic brain at that
given time. Imaging would be advantageous if available, as it would allow a profile of ischemic
damage over time within individual animals.
To ensure a consistent post-stroke environment, all animals were housed individually.
However this may have had a detrimental effect on both behaviour and histology, as social iso-
lation has been associated with increased histological damage and mortality, together with
delayed recovery, an enhanced neuroinflammatory response, oxidative stress and oedema
[90–95].
While the results presented here are based on the thread occlusion model, the lessons can
be extrapolated to any stroke model. Researchers need to be aware of the variability of different
tests and assessment outcomes, and their ability to detect differences both between stroke and
sham animals, and within groups of stroke animals using their model of choice.
Conclusions
What, when and how we assess stroke in animal models need careful consideration in moving
stroke research forward. Traditional outcome measures of histological ischemic damage
showed the progression of damage from an ischemic infarct to fluid filled cavity. When the
degree of oedema or atrophy was accounted for, all timepoints experienced a similar degree of
ischemic damage. Using the adhesive removal test as an example, here we have shown that def-
icits can be detected in stroke animals for up to 6 months after stroke. However sample size
calculations powering an experiment to detect differences between groups of stroke animals
resulted in large cohort sizes that would in most cases, necessitate multi-centre studies. Whilst
long-term studies require an investment of time, finances, and patience, chronic endpoints are
important for examining the long-term effects of a treatment and the inherent plasticity of the
brain and will ultimately draw tighter links between experimental and clinical stroke.
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